Author: admin

Biliary Tract Cancer Market Size (7MM) was found to be ~USD XX Million in 2025 and It is projected to grow at a significant CAGR by 2036, estimates DelveInsight

Biliary Tract Cancer Companies are AstraZeneca, Merck & Co., Compass Therapeutics, NuCana, Senhwa Biosciences, TransThera Sciences, J-Pharma, Eisai, Seagen, Bold Therapeutics, Virogin Biotech, Replimune, Bayer, RedHill Biopharma, Relay Therapeutics, Elevar Therapeutics, Eli Lilly, Cogent Biosciences, and others.

DelveInsight’s “Biliary Tract Cancer Market Insights, Epidemiology, and Market Forecast-2036” report delivers an in-depth understanding of Biliary Tract Cancer, historical and forecasted epidemiology, as well as the Biliary Tract Cancer market trends in the United States, EU4 (Germany, Spain, Italy, and France), and Japan.

Discover Key Insights into the Biliary Tract Cancer Market with DelveInsight’s In-Depth Report @ Biliary Tract Cancer Market Size

Key Takeaways from the Biliary Tract Cancer Market Report

• In January 2026, TransThera Sciences announced presentation of tinengotinib monotherapy in patients with advanced cholangiocarcinoma at American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) 2026.

• According to DelveInsight’s estimates, in 2025, Japan recorded the highest number of incident cases of BTC in the 7MM at approximately 22,000 cases, which are expected to continue increasing at a CAGR of 1.2%.

• In the 7MM, durvalumab (IMFINZI) holds the largest market share in 2025, generating approximately USD 330 million, followed by Pemigatinib (PEMAZYRE).

• In the US, the 65+ age group accounted for approximately 65% of BTC cases in 2025.

• Intrahepatic cholangiocarcinoma (iCCA) has shown a rising incidence trend in Western countries, with Europe experiencing approximately 15-20% annual growth in diagnosis rates.

• The global BTC market is expected to reach USD 4.2 Billion by 2036, driven by expansion of targeted therapies and increased adoption of precision medicine.

• Biomarker testing adoption is projected to increase from current 35% to over 75% by 2030 across the 7MM, significantly influencing treatment selection and market dynamics.

• Combination therapies are anticipated to account for approximately 60% of the BTC market by 2036, up from 40% in 2025.

• The leading Biliary Tract Cancer companies such as AstraZeneca, Merck & Co., Compass Therapeutics, Incyte, Roche/Genentech, Bayer, and others.

• Promising Biliary Tract Cancer Therapies such as Ivosidenib, Pemigatinib, Rilvegostomig, Tinengotinib, Tovecimig, Nanvuranlat, and others.

Stay ahead in the Biliary Tract Cancer Therapeutics Market with DelveInsight’s Strategic Report @ Biliary Tract Cancer Market Outlook

Biliary Tract Cancer Epidemiology Segmentation in the 7MM

• Patient Burden Assessment

• Total Biliary Tract Cancer Incident Cases

• Cholangiocarcinoma Primary Incident Cases

• Gallbladder Cancer Incident Cases

• Ampullary Carcinoma Incident Cases

• Age-specific Incident Cases of Biliary Tract Cancer

• Gender-based Incident Cases of Biliary Tract Cancer

• Mutation-specific Incident Cases of Biliary Tract Cancer (FGFR2, IDH1, BRAF V600E, NTRK, HER2, MSI-H)

• Stage-specific Incident Cases of Biliary Tract Cancer (Localized, Locally Advanced, Metastatic)

• Risk Factor-based Segmentation (Chronic Liver Disease, Bile Duct Inflammation, Infections, Genetic Predisposition)

Download the report to understand which factors are driving Biliary Tract Cancer epidemiology trends @ Biliary Tract Cancer Prevalence

Biliary Tract Cancer Pipeline Analysis

• Pemigatinib (PEMAZYRE): Incyte

Pemigatinib is a kinase inhibitor indicated for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement. This therapy demonstrates strong efficacy in FGFR2-rearranged cholangiocarcinoma and holds the second-largest market share in the 7MM. Patent protection is expected through 2035-2040.

• Ivosidenib (TIBSOVO): Agios Pharmaceuticals/Servier Pharmaceuticals

Ivosidenib is an isocitrate dehydrogenase 1 (IDH1) inhibitor approved for the treatment of cholangiocarcinoma with an IDH1 mutation. It became the first IDH1 inhibitor approved for BTC, targeting approximately 15–20% of cholangiocarcinomas harboring IDH1 mutations, representing a significant therapeutic breakthrough in precision oncology for BTC. Recent Phase III data demonstrates overall response rates exceeding 26% in IDH1-mutant populations.

• Rilvegostomig (AZD2936): AstraZeneca

Rilvegostomig is a first-in-class dual-checkpoint bispecific antibody providing PD-1 and TIGIT blockade on the same immune cell to restore antitumor immunity and enable durable responses. This emerging therapy represents a novel approach in the treatment of immune-resistant Biliary Tract Cancer. Expected US launch targeted for 2030 in first-line settings, with potential peak sales projection of USD 480 million annually.

• Tinengotinib (TT-00420): TransThera Sciences

Tinengotinib is an investigational oral multi-kinase inhibitor for cholangiocarcinoma, especially in patients with FGFR-altered tumors who progressed after prior therapy. It targets FGFR1–3, VEGFR, Aurora, and JAK kinases, with data recently presented at ASCO GI 2026 and a US launch anticipated in 2027. Preliminary efficacy data shows an overall response rate of approximately 32% in FGFR-altered populations.

• Tovecimig (CTX-009): Compass Therapeutics

Tovecimig is a bispecific antibody targeting DLL4 and VEGF-A pathways to inhibit complementary angiogenic mechanisms in advanced BTC. Currently in Phase II/III development, this therapy addresses the hypoxic and angiogenesis-dependent nature of cholangiocarcinomas. Anticipated launch window is 2028-2029 with peak sales projections of USD 350 million.

• Nanvuranlat (JPH203): J-Pharma/OHARA Pharmaceutical

Nanvuranlat is a novel L-type amino acid transporter (LAT1) inhibitor currently in Phase III trials for advanced BTC. This represents a unique mechanistic approach targeting tumor-dependent amino acid metabolism, addressing an unmet therapeutic need. Site activation for the global Beacon-BTC Phase III trial was completed in December 2025, with anticipated regulatory decision by 2028.

Biliary Tract Cancer Drugs Market Insights

Novel targeted therapies and immunotherapies are transforming the treatment landscape of Biliary Tract Cancer. FGFR inhibitors, such as pemigatinib and futibatinib, have expanded treatment options for FGFR2-fusion-positive cholangiocarcinoma with response rates approaching 30%. IDH1 inhibitors, including ivosidenib, are showing promise for IDH1-mutated disease with durable responses extending beyond 12 months in responder populations.

Bispecific antibodies like rilvegostomig and tovecimig are being explored to overcome the immune-resistant nature of BTC through dual immune checkpoint blockade and anti-angiogenic pathways. Emerging LAT1 inhibitors represent a novel class targeting metabolic dependencies in cholangiocarcinoma cells. Multi-kinase inhibitors targeting VEGFR, JAK, and other pathways continue to demonstrate therapeutic potential with synergistic effects in combination regimens.

The integration of immunotherapy with standard chemotherapy has marked the most significant paradigm shift in first-line therapy for BTC, with combination approaches demonstrating 15-20% improvement in overall survival compared to chemotherapy alone. Liquid biopsy technologies and circulating tumor DNA monitoring are increasingly being integrated into clinical practice, enabling real-time treatment response assessment and early detection of resistance mechanisms, expected to improve treatment outcomes by 25-30% by 2030.

Cell-surface antigen targeting through CAR-T cell therapy approaches for BTC-specific antigens are currently in preclinical development, with Phase I trials anticipated to initiate by 2027. Additionally, small molecule inhibitors targeting the Wnt/β-catenin pathway are showing preliminary efficacy in preclinical models of BTC stem cells, representing a potential avenue for addressing treatment-resistant populations.

Get In-Depth Knowledge on Biliary Tract Cancer Market Trends and Forecasts with DelveInsight @ Biliary Tract Cancer Treatment Market

Biliary Tract Cancer Market Outlook

Biliary Tract Cancer represents a rare but highly lethal group of malignancies with an overall 5-year survival rate of approximately 15%, dropping to 8.5% for intrahepatic cholangiocarcinoma, particularly in patients with metastatic disease. However, outcomes in biomarker-selected populations receiving targeted therapies demonstrate significantly improved progression-free survival rates of 8-12 months compared to 4-6 months with chemotherapy alone. Curative treatment relies on surgical resection, with chemotherapy serving as the primary systemic therapy for advanced or unresectable disease. Platinum-based combination chemotherapy has historically served as the backbone of systemic therapy in advanced or unresectable disease across the 7MM.

Recent regulatory approvals have significantly expanded treatment options. The approval of durvalumab in combination with gemcitabine and cisplatin for first-line treatment of locally advanced or metastatic BTC marked the first immunotherapy-based regimen approved in the frontline setting, with initial 2-year follow-up data demonstrating durable remissions in 22% of treated patients. The market is experiencing a paradigm shift from a “one-size-fits-all” chemotherapy approach to a highly segmented, biomarker-driven landscape, with targeted therapies addressing molecular alterations including FGFR2 fusions (detected in 10-15% of cases), IDH1 mutations (15-20%), BRAF V600E (5-7%), NTRK fusions (1-2%), HER2 amplification (3-5%), and MSI-H (2-3%).

The adoption of next-generation sequencing (NGS) for comprehensive genomic profiling is accelerating, with approximately 45% of treatment-naïve BTC patients currently undergoing molecular testing, expected to reach 75% by 2030. This expansion will unlock access to targeted therapies for additional patient populations and enable development of novel biomarker combinations.

Despite recent therapeutic advances, critical unmet needs remain, including the absence of reliable, non-invasive biomarkers for early detection with sensitivity >85% and specificity >90%, and the lack of predictive markers accurately identifying patients with durable immunotherapy response. Current clinical response prediction models achieve only 60% accuracy, necessitating development of improved multi-omics biomarker panels. Additionally, the development of strategies to overcome acquired resistance to FGFR inhibitors, observed in approximately 30-40% of patients after 12-18 months of treatment, remains a critical priority. Geographic disparities in treatment access, particularly in resource-limited regions where BTC incidence is highest, underscore the need for more affordable therapeutic options and improved healthcare infrastructure.

Scope of the Biliary Tract Cancer Market Report

• Coverage- 7MM

• Study Period- 2020-2034

• Forecast Period- 2024-2036

• Historical Market Size Analysis and Forecasted Market Growth (2022-2036)

• Biliary Tract Cancer Companies- AstraZeneca, Merck & Co., Compass Therapeutics, Incyte, Roche/Genentech, Bayer, Eisai, Seagen, and others.

• Biliary Tract Cancer Therapies- Ivosidenib, Pemigatinib, Rilvegostomig, Tinengotinib, Tovecimig, Nanvuranlat, Futibatinib, Durvalumab, and others.

• Biliary Tract Cancer Market Access & Reimbursements, Unmet Needs and Perspectives

• Biomarker Testing Adoption Rates and Impact on Market Dynamics

• Real-World Evidence and Treatment Pattern Analysis

• Pricing and Reimbursement Scenario Across Different Healthcare Systems

• Biliary Tract Cancer SWOT Analysis and KOL Views

• Competitive Landscape and Market Share Projections

• Pipeline Analysis with Phase-Specific Breakdown and Probability of Success Estimations

Unlock Strategic Insights with DelveInsight’s Comprehensive Biliary Tract Cancer Market Report @ Biliary Tract Cancer Market Drivers and Barriers

Table of Contents

  1. Key Insights

  2. Report Introduction

  3. Executive Summary

  4. Key Events

  5. Epidemiology and Market Forecast Methodology

  6. Biliary Tract Cancer (BTC) Market Overview at a Glance

  7. Disease Background and Overview of Biliary Tract Cancer (BTC)

  8. Epidemiology and Patient Population of Biliary Tract Cancer (BTC)

  9. Patient Journey of Biliary Tract Cancer (BTC)

  10. Marketed Therapies of Biliary Tract Cancer (BTC)

  11. Emerging Therapies of Biliary Tract Cancer (BTC)

  12. Biliary Tract Cancer (BTC): 7MM Analysis

  13. Unmet Needs of Biliary Tract Cancer (BTC)

  14. SWOT Analysis of Biliary Tract Cancer (BTC)

  15. KOL Views of Biliary Tract Cancer (BTC)

  16. Market Access and Reimbursement of Biliary Tract Cancer (BTC)

  17. Appendix

  18. DelveInsight Capabilities

  19. Disclaimer

  20. About DelveInsight

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kanishk Kumar
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Biliary Tract Cancer Market Size (7MM) was found to be ~USD XX Million in 2025 and It is projected to grow at a significant CAGR by 2036, estimates DelveInsight

Global Helicobacter Pylori (H. pylori) Infection Market to Witness Significant Growth Through 2032, Driven by Advancements in Diagnostics and Emerging Therapeutic Strategies, Reveals DelveInsightHelic

DelveInsight’s “Helicobacter Pylori (H. pylori) Infection Market Insights, Epidemiology, and Market Forecast-2032” report provides a comprehensive analysis of the disease landscape, epidemiology trends, current treatment practices, emerging therapies, market dynamics, and competitive intelligence across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

The global Helicobacter Pylori (H. pylori) Infection market is expected to experience substantial growth during the forecast period 2023–2032, fueled by increasing disease awareness, advancements in diagnostic technologies, rising healthcare expenditure, and ongoing development of targeted therapies. According to DelveInsight’s latest report, the H. pylori Infection market across the seven major markets (7MM) was valued at nearly USD 3,489 million in 2022 and is anticipated to witness significant transformation over the coming years.

Download the free sample report to explore the Helicobacter Pylori Infection market in detail: Helicobacter Pylori Infection Market Forecast

Key Highlights From the Helicobacter Pylori Infection Market Report

  • The Helicobacter Pylori Infection market is projected to expand steadily through 2032 due to increasing disease prevalence, improved diagnostic capabilities, and the emergence of novel therapeutic approaches aimed at enhancing eradication rates and minimizing antibiotic resistance.

  • The market size of Helicobacter Pylori Infection across the 7MM reached approximately USD 3,489 million in 2022 and is expected to grow significantly during the forecast period.

  • Key companies operating in the Helicobacter Pylori Infection market include DiaSorin SpA, bioMerieux SA, Thermo Fisher Scientific Inc, Meridian Bioscience Inc, Avanos Medical Inc, and other major diagnostics and therapeutics providers.

  • The report highlights increasing research efforts focused on improving treatment efficacy, optimizing antibiotic combinations, and advancing non-invasive diagnostic testing technologies.

  • Ongoing developments in personalized medicine, antimicrobial stewardship, and next-generation molecular diagnostics are expected to reshape the H. pylori treatment landscape in the coming years.

Understanding Helicobacter Pylori (H. pylori) Infection

Helicobacter Pylori (H. pylori) Infection is a bacterial infection caused by Helicobacter pylori, a spiral-shaped gram-negative bacterium that colonizes the stomach lining. It is one of the most common chronic bacterial infections globally and is strongly associated with gastritis, peptic ulcer disease, mucosa-associated lymphoid tissue lymphoma, and gastric cancer.

The infection is typically acquired during childhood and can persist lifelong if left untreated. Common symptoms include abdominal pain, bloating, nausea, indigestion, loss of appetite, and in severe cases gastrointestinal bleeding.

The growing burden of antibiotic resistance has become a major clinical challenge in H. pylori management, emphasizing the need for more effective treatment regimens and innovative therapeutic approaches.

Access a free sample PDF to explore the H. pylori therapeutic landscape: Helicobacter Pylori Infection Epidemiology Insights

Helicobacter Pylori (H. pylori) Infection Epidemiology Insights

The epidemiology section of the report provides detailed historical and forecasted trends of H. pylori infection across the seven major markets from 2019 to 2032.

Key epidemiological insights include:

  • Total diagnosed prevalent cases of H. pylori infection in the 7MM

  • Gender-specific diagnosed prevalent cases

  • Age-specific diagnosed prevalent cases

  • Country-wise epidemiological analysis across the United States, EU5, and Japan

The report enables stakeholders to better understand disease burden, patient demographics, and evolving epidemiological trends supporting strategic planning and commercial decision-making.

Helicobacter Pylori (H. pylori) Infection Diagnosis and Treatment Landscape

The report offers a detailed overview of current diagnostic and treatment practices for H. pylori infection.

Diagnosis

Diagnostic approaches covered in the report include:

  • Urea breath tests

  • Stool antigen tests

  • Endoscopic biopsy

  • Histology and culture testing

  • Molecular and serological diagnostics

Advancements in non-invasive testing and molecular diagnostics are improving early detection and treatment monitoring capabilities.

Treatment

The treatment landscape analysis includes:

  • Conventional antibiotic-based triple and quadruple therapies

  • Proton pump inhibitor combinations

  • Bismuth-containing regimens

  • Sequential and concomitant therapies

  • Regional treatment guidelines across the US, Europe, and Japan

The report also discusses challenges associated with antibiotic resistance and the growing demand for more effective and personalized treatment strategies.

Helicobacter Pylori (H. pylori) Infection Drug Chapters

The report provides comprehensive analysis of marketed products and emerging pipeline therapies under development for H. pylori infection treatment.

Marketed Therapies

The report covers currently available therapies and off-label treatment options utilized in clinical practice for H. pylori eradication.

Emerging Therapies

The pipeline section evaluates late-stage and mid-stage therapies designed to improve eradication rates, reduce resistance-related failures, and enhance patient compliance.

The report further analyzes:

  • Clinical trial activities

  • Pharmacological mechanisms

  • Licensing and collaboration agreements

  • Patent and regulatory developments

  • Recent company updates and strategic initiatives

Helicobacter Pylori (H. pylori) Infection Market Outlook

The Helicobacter Pylori Infection market outlook section delivers detailed insights into current and forecasted market trends by evaluating:

  • Existing and emerging therapies

  • Unmet clinical needs

  • Market drivers and barriers

  • Therapy-specific uptake trends

  • Competitive positioning of marketed and pipeline products

The report also assesses annual therapy costs, expected launch timelines, patient eligibility criteria, market penetration potential, and key opinion leader perspectives influencing future adoption trends.

According to DelveInsight, the Helicobacter Pylori Infection market across the 7MM is anticipated to undergo significant transformation during the forecast period 2019–2032: https://www.delveinsight.com/report-store/helicobacter-pylori-h-pylori-infection-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=mpr

Regional Helicobacter Pylori Infection Market OutlookUnited States Market Outlook

This section provides detailed analysis of the total H. pylori Infection market size and therapy-specific market trends in the United States.

EU5 Market Outlook

Comprehensive market analysis is provided for Germany, France, Italy, Spain, and the United Kingdom, covering current and forecasted therapy adoption trends.

Japan Market Outlook

The report also evaluates the H. pylori Infection market dynamics and therapy landscape in Japan.

Helicobacter Pylori (H. pylori) Infection Drugs Uptake and Pipeline Development Activities

The report evaluates the expected uptake of recently launched and upcoming therapies during the study period 2019–2032. The analysis focuses on:

  • Patient uptake trends

  • Therapy adoption rates

  • Market share analysis

  • Commercial potential of pipeline candidates

Additionally, the report highlights:

  • Phase II and Phase III pipeline candidates

  • Collaborations and licensing agreements

  • Mergers and acquisitions

  • Patent activities

  • Strategic partnerships influencing market expansion

Reimbursement Scenario in Helicobacter Pylori (H. pylori) Infection

The report provides valuable reimbursement insights supporting strategic market access planning. It evaluates pricing and reimbursement challenges across key geographies while identifying commercially attractive markets with lower reimbursement barriers.

KOL Views and Competitive Intelligence Analysis

To validate secondary research findings and assess evolving treatment trends, DelveInsight incorporates perspectives from key opinion leaders (KOLs) and subject matter experts working in the H. pylori Infection domain.

The report also includes extensive competitive intelligence analysis utilizing tools such as:

  • SWOT Analysis

  • PESTLE Analysis

  • Porter’s Five Forces

  • BCG Matrix

  • Market Entry Strategies

These insights support stakeholders in identifying future opportunities and competitive positioning within the evolving market landscape.

Helicobacter Pylori (H. pylori) Infection Market Drivers and ChallengesKey Market Drivers

  • Increasing awareness and diagnosis of H. pylori infection

  • Rising prevalence of gastric disorders associated with H. pylori

  • Advancements in molecular diagnostics and non-invasive testing

  • Growing healthcare expenditure globally

  • Ongoing research into improved eradication therapies

Key Market Challenges

  • Rising antibiotic resistance reducing treatment efficacy

  • Recurrence and reinfection risks

  • Variability in treatment guidelines across regions

  • Limited pipeline innovation in some therapeutic areas

  • Reimbursement and pricing challenges

Download sample report now -https://www.delveinsight.com/report-store/helicobacter-pylori-h-pylori-infection-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=mpr

Helicobacter Pylori (H. pylori) Infection Report Scope

The report offers global coverage with focus on:

  • Historical and forecasted market trends from 2019 to 2032

  • Epidemiology analysis across the 7MM

  • Current and emerging therapies

  • Competitive landscape and pipeline assessment

  • Market drivers, barriers, and unmet needs

  • Strategic insights for stakeholders and healthcare companies

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharmaceutical and biotechnology companies by providing comprehensive end-to-end solutions to improve business performance and strategic decision-making.

Media Contact
Company Name: DelveInsight
Contact Person: Mehul Malhotra
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Global Helicobacter Pylori (H. pylori) Infection Market to Witness Significant Growth Through 2032, Driven by Advancements in Diagnostics and Emerging Therapeutic Strategies, Reveals DelveInsightHelic

Burnett Law Office Shares Safety Awareness Tips for Arizona Drivers During Busy Late Spring and Early Summer Travel Season

As schools across Arizona begin wrapping up for the year and families start preparing for vacations and holiday travel, Burnett Law Office is encouraging drivers to prioritize roadway safety during the busy late spring and early summer travel season.

According to the firm, increased traffic volume during this time of year can contribute to a higher risk of serious vehicle accidents throughout Arizona. Families traveling for graduations, weekend getaways, sporting events, and early summer vacations often lead to heavier congestion on major highways and local roadways across the state.

Burnett Law Office notes that distracted driving, speeding, fatigue, and aggressive driving behaviors continue to be among the leading causes of accidents during seasonal travel periods. Increased traffic involving passenger vehicles, motorcycles, RVs, and commercial trucks can also create more hazardous driving conditions, particularly along heavily traveled interstate corridors throughout Arizona.

The firm encourages drivers to take extra precautions before heading out on longer trips, including planning routes ahead of time, avoiding distracted driving behaviors, allowing additional travel time, and ensuring vehicles are properly maintained before travel begins. Drivers are also reminded to stay alert in construction zones and high-traffic areas where sudden slowdowns may occur.

Burnett Law Office says accidents involving larger commercial vehicles can often result in particularly serious injuries due to the size and weight differences involved. Sharing the road safely with commercial trucks and maintaining safe following distances can help reduce collision risks during periods of increased highway traffic.

The attorneys at Burnett Law Office provide aggressive and compassionate legal help to injury and accident victims who have been hurt or injured as a result of another’s negligence. The firm handles a wide range of personal injury matters, including car accidents, semi-truck accidents, wrongful death cases, and other serious injury claims throughout Arizona.

The firm also encourages accident victims to seek medical attention promptly following any collision and to carefully document injuries, vehicle damage, and accident details whenever possible. Early documentation may become important during the insurance and legal claims process.

Burnett Law Office serves clients throughout Arizona from its office in Mesa and provides legal representation for individuals and families involved in serious personal injury and accident cases.

For more information, visit Burnett Law Office or call (480) 347-9116.

Media Contact
Company Name: Burnett Law Office
Contact Person: Media Contact
Email: Send Email
Phone: (480) 347-9116
Address:1744 S. Val Vista Dr. #208
City: Mesa
State: AZ
Country: United States
Website: www.burnettlawaz.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Burnett Law Office Shares Safety Awareness Tips for Arizona Drivers During Busy Late Spring and Early Summer Travel Season

Hammond Services Shares the Importance of Electrical Inspections Ahead of Storm Season in Austell and West Metro Atlanta

As storm season approaches in Austell and across West Metro Atlanta, homeowners are encouraged to take proactive steps to protect their properties from potential electrical hazards.

Hammond Services is helping residents understand why scheduling a professional electrical inspection before severe weather arrives is an important part of home safety and preparedness.

Spring and early summer storms in Georgia often bring heavy rain, strong winds, and lightning, all of which can place significant stress on a home’s electrical system. Without proper preparation, these conditions can lead to power surges, outages, and damage to wiring, panels, and connected appliances.

A comprehensive electrical inspection can help identify potential issues before they become serious problems. During an inspection, key components such as the electrical panel, circuit breakers, wiring, and grounding systems are evaluated to ensure they are functioning properly and safely. These systems play a critical role in protecting homes during storms, particularly when sudden voltage spikes occur.

One of the most common risks during storm season is power surges caused by lightning strikes or fluctuations in the electrical grid. An inspection can help determine whether a home is properly equipped with surge protection or if upgrades, such as whole-home surge protection, may be beneficial. These systems help safeguard electronics, appliances, and HVAC equipment from unexpected electrical damage.

Older homes in Austell and surrounding West Metro Atlanta communities may be more vulnerable if their electrical systems have not been updated to handle modern energy demands. As homeowners continue to add devices and appliances, ensuring the system can safely manage increased loads is essential.

Electrical inspections can also help reduce the risk of fire hazards. Faulty wiring, loose connections, and worn components can become dangerous when exposed to the added stress of severe weather. Identifying and addressing these concerns early provides homeowners with added peace of mind during storm season.

Hammond Services provides professional electrical services for homeowners throughout Austell and West Metro Atlanta, including inspections, panel upgrades, surge protection, and system improvements. Their team works closely with customers to ensure electrical systems are safe, reliable, and prepared for changing weather conditions.

Taking action before storms become more frequent can help homeowners avoid unexpected disruptions and costly repairs. By scheduling an electrical inspection in advance, residents can better protect their homes and maintain dependable power throughout the season.

Homeowners in Austell and West Metro Atlanta can learn more about electrical inspection services by visiting www.hammondservices.com or calling (770) 450-4981 to schedule an appointment.

About Hammond Services

Hammond Services provides HVAC and electrical services for residential and commercial customers in Austell, GA, and throughout West Metro Atlanta. The company offers a full range of services including electrical inspections, panel upgrades, surge protection, heating and cooling maintenance, and system installations. With a commitment to quality workmanship and customer satisfaction, Hammond Services helps homeowners maintain safe, efficient, and reliable home systems year-round.

Media Contact
Company Name: Hammond Services
Contact Person: Media Contact
Email: Send Email
Phone: (770) 450-4981
Address:6630 Oak Ridge Commerce Way
City: Austell
State: GA
Country: United States
Website: www.hammondservices.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Hammond Services Shares the Importance of Electrical Inspections Ahead of Storm Season in Austell and West Metro Atlanta

Hammond Services Highlights Ways to Boost Indoor Air Quality This Spring in Newnan and Griffin Homes

As spring arrives in Newnan, Griffin, and across South Metro Atlanta, many homeowners begin to notice an increase in allergens such as pollen, dust, and airborne particles inside their homes.

Hammond Services is helping local residents understand how improving indoor air quality can enhance comfort, support healthier living environments, and reduce the impact of seasonal allergies.

During the spring months, pollen levels in Georgia can be especially high, often finding their way indoors through open doors, windows, and HVAC systems. Once inside, these particles can circulate throughout the home, affecting air quality and contributing to allergy symptoms. Without proper filtration and maintenance, indoor air can become more polluted than many homeowners realize.

One of the most effective ways to improve indoor air quality is through regular HVAC maintenance. Changing air filters on a consistent basis helps trap dust, pollen, and other airborne contaminants before they can circulate through the home. High-efficiency filters can provide even greater protection, particularly for households with allergy sensitivities.

Proper ventilation also plays an important role in maintaining clean indoor air. Ensuring that HVAC systems are operating efficiently and that air is circulating properly can help reduce the buildup of stale or contaminated air. In some cases, additional solutions such as air purification systems or UV lights can be installed to further improve air quality by targeting bacteria, mold spores, and other pollutants.

Humidity control is another key factor, especially in the South Metro Atlanta area where spring conditions can bring increased moisture. High humidity levels can create an environment where mold and mildew thrive, negatively impacting both air quality and the condition of the home. Dehumidification solutions can help maintain balanced humidity levels and reduce the risk of mold growth.

Ductwork should also be inspected periodically, as dust and debris can accumulate over time and be distributed throughout the home. Addressing these issues can help ensure that the air circulating through the HVAC system is as clean as possible.

Hammond Services works with homeowners throughout Newnan, Griffin, and South Metro Atlanta to evaluate indoor air quality and recommend solutions tailored to each home’s needs. From routine HVAC maintenance to advanced air quality systems, their team helps create healthier and more comfortable living environments.

Taking steps to improve indoor air quality during the spring season can make a noticeable difference in overall comfort and well-being. By addressing common sources of indoor pollutants, homeowners can better enjoy their homes throughout the warmer months ahead.

Homeowners in Newnan, Griffin, and South Metro Atlanta can learn more about indoor air quality solutions by visiting www.hammondservices.com or calling (770) 762-5393 to schedule a service.

About Hammond Services

Hammond Services provides professional HVAC and electrical services for residential and commercial customers in Newnan, Griffin, and throughout South Metro Atlanta. The company offers a full range of services including heating and cooling maintenance, repairs, installations, and indoor air quality solutions. With a commitment to quality workmanship and customer satisfaction, Hammond Services helps homeowners maintain safe, comfortable, and energy-efficient homes year-round.

Media Contact
Company Name: Hammond Services
Contact Person: Media Contact
Email: Send Email
Phone: (770) 762-5393
Address:644 East McIntosh Rd
City: Griffin
State: GA
Country: United States
Website: www.hammondservices.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Hammond Services Highlights Ways to Boost Indoor Air Quality This Spring in Newnan and Griffin Homes

Wild Weather Service and Brian Ohm Unveil Historic Record Breaking Long-Range Precision Tornado and Hurricane Forecasting

MIAMI, FL – May 27, 2026 – Wild Weather Service, a leader in precision meteorological analytics, today announced the formal expansion of its revolutionary Localization Forecasting protocols. Spearheaded by Director Brian Ohm, these proprietary models have fundamentally shifted the paradigm of severe weather alerts, moving from broad regional “watches” to city-specific “impact zones” with timelines previously thought impossible in modern meteorology.

Hurricane Forecasting: From Days to Years

While traditional meteorological agencies typically provide a five-day “cone of uncertainty,” Wild Weather Service has demonstrated the capability to identify specific hurricane impact zones up to 21 months in advance. This ultra-long-range capability allows for a radical restructuring of disaster preparedness.

  • Historical Accuracy: The service gained national attention for its precise analysis of the 2024 hurricane season, where it accurately localized catastrophic risks for the Tampa and New Orleans metro areas nearly two years prior to landfall.
  • Economic Mitigation: By identifying approximately $460 billion in potential future property and infrastructure damage across the Atlantic and Gulf coasts, Brian Ohm’s models provide insurance conglomerates and municipal governments with the data necessary to harden infrastructure long before a storm even forms in the Atlantic.


Tornado Localization: The 24-Hour “Bullseye” Advantage

Perhaps the most life-saving application of Ohm’s research is in the field of tornadic activity. Since 2022, Wild Weather Service has moved away from the standard “watch” area—which often encompasses tens of thousands of square miles—to a localized “Bullseye” method.

  • Proven Track Record: Over the past four years, the service has successfully localized the strike zones of over 680+ tornadoes across the United States since 2022.
  • Actionable Lead Times: While the industry average for a tornado warning is approximately 13 minutes, Brian Ohm’s localization mapping provides high-risk municipalities with 24-hour lead times and longer. Often supplying 1-6 day ahead Tornado Bullseye areas.

The Visionary Behind the Science

The inception of these localization maps followed a collaborative spirit with federal interests, including a request from the National Weather Service (NWS) to investigate more granular solutions for severe weather. Brian Ohm’s subsequent breakthroughs between 2021 and 2026 have filled a critical gap in public safety.

“We are not content with telling people that a storm is coming ‘somewhere’ in their state,” said Brian Ohm, Director of Wild Weather Service. “Our mission to save lives and property by advanced precision storm zone forecasting.” The foundation of all American lives being upgraded with greater safety than was available.

About Wild Weather Service

Founded on the principle that precision equals protection, Wild Weather Service is the first private meteorological firm to achieve high-accuracy localization for extreme convective and cyclonic events. Through proprietary algorithms and historical pattern recognition, the firm serves as a critical bridge between atmospheric science and emergency management.

WildWeatherService.com

Linkedin – Brian Ohm

Facebook – Wild Weather Service

Media Contact
Company Name: Wild Weather Service
Contact Person: Brian Ohm
Email: Send Email
Country: United States
Website: WildWeatherService.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Wild Weather Service and Brian Ohm Unveil Historic Record Breaking Long-Range Precision Tornado and Hurricane Forecasting

Asia Pacific Retail Pharmacy Market to Reach USD 524.8 Billion Driven by Aging Population and E-Pharmacy Expansion

According Credence Research, the Asia Pacific Retail Pharmacy Market was valued at USD 344.9 billion in 2024 and is projected to reach USD 524.8 billion by 2032, expanding at a CAGR of 5.39% during the forecast period.

Credence Research has published a new research report titled “Asia Pacific Retail Pharmacy Market Size, Share, Growth, Opportunities, and Competitive Analysis, 2025–2032.” According to the study, the Asia Pacific Retail Pharmacy Market was valued at USD 344.9 billion in 2024 and is projected to reach USD 524.8 billion by 2032, expanding at a CAGR of 5.39% during the forecast period. The market is growing faster than the global retail pharmacy market, which is expected to rise from USD 1,445.9 billion in 2024 to USD 1,965.9 billion by 2032, at a CAGR of 3.92%.

The Asia Pacific Retail Pharmacy Market is gaining strong momentum due to rising demand for prescription medicines, OTC products, chronic disease management support, and consumer health products. Aging populations in countries such as Japan, South Korea, and China continue to increase demand for long-term medication access and disease management services. At the same time, growing healthcare awareness, expanding pharmacy chains, and government initiatives to improve healthcare access are strengthening the role of retail pharmacies across urban and rural markets. E-pharmacy platforms are also transforming the sector by offering home delivery, online consultations, digital prescriptions, and wider medicine availability.

Asia Pacific Retail Pharmacy Market Insights

  • The Asia Pacific Retail Pharmacy Market was valued at USD 344.9 billion in 2024 and is projected to reach USD 524.8 billion by 2032, growing at a CAGR of 5.39% during the forecast period.
  • The Global Retail Pharmacy Market is projected to grow from USD 1,445.9 billion in 2024 to USD 1,965.9 billion by 2032, registering a CAGR of 3.92%.
  • Market growth is driven by rising demand for OTC medications, prescription drugs, chronic disease support, and wellness products across Asia Pacific.
  • E-pharmacy services are reshaping the retail pharmacy model through home delivery, online consultation, digital ordering, and wider consumer reach.
  • East Asia, especially Japan and China, dominates the regional market due to large populations, strong healthcare spending, and mature pharmacy infrastructure.

 

Browse the report – https://www.credenceresearch.com/report/asia-pacific-retail-pharmacy-market

 

Asia Pacific Retail Pharmacy Market Growth Drivers

Rising Demand for Prescription and OTC Medicines

The increasing burden of chronic diseases and rising consumer awareness of preventive healthcare are driving demand for both prescription and over-the-counter medicines. Retail pharmacies serve as a critical access point for medicines, particularly in densely populated urban markets and underserved rural areas. Growing demand for pain relief products, vitamins, supplements, digestive health products, cold and flu medicines, and chronic disease medications continues to support steady market expansion.

Aging Population and Chronic Disease Management

Aging demographics across Japan, South Korea, China, and other Asia Pacific countries are significantly increasing demand for long-term medication support. Older consumers require continuous access to medicines for diabetes, hypertension, cardiovascular diseases, arthritis, respiratory conditions, and other chronic illnesses. Retail pharmacies are expanding their services beyond medicine dispensing by offering refill management, patient counseling, adherence support, and wellness products. This shift strengthens their role in chronic disease management and improves long-term customer retention.

Expansion of Retail Pharmacy Chains

The growth of organized pharmacy chains across urban and semi-urban markets is improving medicine accessibility and service consistency. Chain pharmacies benefit from stronger procurement systems, wider product portfolios, better inventory management, and standardized customer service. Their expansion into rural and underserved areas is also improving healthcare reach, especially where hospitals and clinics remain limited. Large pharmacy networks are increasingly combining prescription medicines, OTC products, personal care items, and health consultation services under one retail model.

Rapid Growth of E-Pharmacy Platforms

E-pharmacy is emerging as a major growth driver in Asia Pacific. Online pharmacy platforms provide convenience through doorstep delivery, digital prescriptions, subscription refills, and teleconsultation-linked medicine ordering. These platforms are particularly attractive for elderly patients, working professionals, and consumers managing chronic diseases. E-pharmacies also help improve medicine access in smaller cities and remote areas, expanding the addressable customer base for pharmacy operators.

Asia Pacific Retail Pharmacy Market Trends and Opportunities

Diversification into Healthcare and Wellness Services

Retail pharmacies are increasingly expanding beyond medicine sales into wellness products, health screenings, basic consultations, nutrition products, and chronic disease support services. This diversification improves customer engagement and creates new revenue streams. Pharmacies that combine product availability with patient support services are better positioned to build long-term consumer loyalty.

Integration of Digital Health and Pharmacy Services

Digital transformation is reshaping pharmacy operations across Asia Pacific. Pharmacies are adopting mobile apps, online refill systems, digital payment solutions, electronic prescriptions, and inventory management platforms. These tools improve operational efficiency and enhance customer convenience. Integration with telemedicine platforms also creates opportunities for seamless consultation-to-medication delivery models.

Growth in Rural and Semi-Urban Pharmacy Networks

Government healthcare-access initiatives and private-sector expansion are increasing pharmacy penetration in rural and semi-urban regions. These markets offer significant growth potential due to rising healthcare awareness, improving income levels, and limited availability of formal healthcare services. Retail pharmacies can play a major role in bridging medicine access gaps across underserved populations.

Asia Pacific Retail Pharmacy Market Challenges

High Competition and Pricing Pressure

The market is highly competitive, with organized chains, independent pharmacies, hospital pharmacies, and online platforms all competing for customers. Price sensitivity remains strong in many Asia Pacific markets, especially where consumers prefer lower-cost generic medicines. This puts pressure on pharmacy margins and forces operators to improve efficiency, expand service offerings, and strengthen customer loyalty.

Regulatory Complexity Across Countries

Different countries in Asia Pacific have varied rules for pharmacy licensing, prescription handling, drug pricing, online medicine sales, and generic substitution. These regulatory differences create compliance challenges for companies expanding across multiple markets. E-pharmacy operators face additional scrutiny related to prescription validation, medicine authenticity, data privacy, and cross-border distribution.

Asia Pacific Retail Pharmacy Market Regional Analysis

East Asia

East Asia dominates the Asia Pacific Retail Pharmacy Market, led by Japan and China. Japan benefits from a rapidly aging population, advanced healthcare infrastructure, and strong demand for prescription medicines and chronic disease management services. China contributes significantly due to its large population, expanding healthcare expenditure, and increasing role of organized pharmacy chains and online pharmacy platforms.

Southeast Asia

Southeast Asia is experiencing strong growth due to rising healthcare awareness, expanding middle-class populations, and improving retail healthcare infrastructure. Countries such as Indonesia, Thailand, Vietnam, Malaysia, and the Philippines are witnessing increasing demand for OTC medicines, wellness products, and pharmacy-based healthcare services.

South Asia

South Asia, led by India, offers major growth opportunities due to expanding pharmacy chains, strong generic drug availability, and rising demand for affordable healthcare access. Organized pharmacy players and e-pharmacy platforms are scaling rapidly in urban and semi-urban markets.

Australia and South Korea

Australia and South Korea represent mature and high-value pharmacy markets. Demand is supported by strong healthcare systems, high consumer awareness, and growing emphasis on preventive care, wellness products, and chronic medication management.

Competitive Landscape

The Asia Pacific Retail Pharmacy Market features a competitive mix of regional chains, healthcare retailers, convenience-store pharmacy models, and digital pharmacy platforms. CK Life Sciences, MedPlus, Watsons, Apollo Pharmacy, and 7-Eleven are among the key players operating across the regional pharmacy ecosystem. Companies compete through store expansion, digital platforms, private-label products, medicine delivery services, loyalty programs, and diversified healthcare offerings. Global retail pharmacy operators and local brands continue expanding their footprint to capture demand from urban, semi-urban, and online consumer segments.

Asia Pacific Retail Pharmacy Market Outlook 2032

The Asia Pacific Retail Pharmacy Market is expected to maintain steady expansion through 2032 as medicine demand rises, healthcare access improves, and e-pharmacy models become more mainstream. Aging populations will continue to drive prescription drug consumption, while younger consumers will support growth in wellness, OTC, and digital pharmacy services. Retail pharmacies that integrate physical stores with online platforms, home delivery, chronic care support, and wellness offerings will be better positioned to capture long-term growth.

ATTRIBUTE DETAILS

ATTRIBUTE

DETAILS

Research Period

2020–2032

Base Year

2024

Forecast Period

2025–2032

Historical Year

2020–2023

Unit

USD Billion

By Product Type (2020–2032; USD Billion)

Prescription Drugs; OTC Drugs; Health & Wellness Products; Personal Care Products; Others

By Pharmacy Type (2020–2032; USD Billion)

Chain Pharmacies; Independent Pharmacies; Hospital-Based Retail Pharmacies; E-Pharmacies

By Service Type (2020–2032; USD Billion)

Medicine Dispensing; Online Consultation Support; Home Delivery; Chronic Disease Management; Wellness Services

By Geography (2020–2032; USD Billion)

China; Japan; India; South Korea; Southeast Asia; Australia; Rest of Asia Pacific

 

Preview the report with a detailed sample and understand how it can benefit your business strategy. Request a free sample today – https://www.credenceresearch.com/report/asia-pacific-retail-pharmacy-market

 

Discover additional reports tailored to your industry needs –

 

Europe Retail Pharmacy Market – https://www.credenceresearch.com/report/europe-retail-pharmacy-market

Global Retail Pharmacy Market – https://www.credenceresearch.com/report/retail-pharmacy-market

 

Media Contact
Company Name: Credence Research
Contact Person: Mitul Dean
Email: Send Email
Phone: +91 6232 49 3207
Address:Credence Research Inc, Tower C-1105 , S 25, Akash Tower, Vishal Nagar, Pimple Nilakh, Haveli,
City: Pune
State:
Country: India
Website: https://www.credenceresearch.com/report/asia-pacific-retail-pharmacy-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Asia Pacific Retail Pharmacy Market to Reach USD 524.8 Billion Driven by Aging Population and E-Pharmacy Expansion

Agentic AI Security Market Growth Accelerates with AI Governance and Autonomous Threat Detection Demand Forecast To 2032

“Palo Alto Networks(US), CrowdStrike(US), Straiker, SentinelOne (US), Okta (US), Cloudflare (US), Cato Networks (Israel), Check Point Software Technologies (Israel), Securiti (US), HiddenLayer (US), Noma Security (Israel), Obsidian Security (US), Mindgard (UK).”
Agentic AI Security Market by Security Function, Tool (Prompt Security Tools, Guardrail Frameworks, Al Pen Testing & Red Teaming Tools, Guardrail Frameworks), Deployment Layer – Global Forecast to 2032.

The Agentic AI Security Market is expected to expand at a compound annual growth rate (CAGR) of 42.0% from USD 1.65 billion in 2026 to USD 13.52 billion by 2032. The need for sophisticated cybersecurity solutions is being driven by the growing use of multi-agent AI systems in business settings. The complexity of protecting these ecosystems increases as more agents communicate, exchange information, and carry out activities independently. To stop illegal activity and guarantee safe cooperation between agents, organizations need constant monitoring, coordination, security, and behavior analysis.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=97017233

Rising cyber threats targeting AI training and inference environments are driving demand for specialized cybersecurity solutions. Attackers are increasingly exploiting vulnerabilities in datasets, models, and runtime processes through data poisoning, model manipulation, and inference attacks. As enterprises rely more on AI-driven decisions, securing these environments becomes critical to ensure accuracy, integrity, and resilience.

By organization size, the SMEs segment is expected to register the highest CAGR during the forecast period.

SMEs are expected to witness the fastest growth in the agentic AI security market as they increasingly adopt AI-driven tools and autonomous systems to improve operational efficiency and decision-making. Unlike large enterprises, SMEs are often moving directly toward AI-native applications, including agent-based automation across customer service, marketing, and operations. This rapid adoption is exposing them to new security risks, including unauthorized agent actions, data leakage, and vulnerabilities in AI models. At the same time, SMEs typically have limited in-house cybersecurity expertise and resources, making them more reliant on external solutions. This is driving strong demand for managed security services, AI-native security platforms, and easy-to-deploy tools that can provide protection without requiring deep technical expertise. As awareness of AI-related risks continues to grow and more SMEs integrate autonomous systems into their workflows, their spending on agentic AI security is expected to increase at a faster pace compared to large enterprises, making this segment the fastest-growing in the market.

By deployment mode, the infrastructure layer segment is estimated to lead the market during the forecast period.

The infrastructure layer segment is expected to hold the largest share of the agentic AI security market, as it represents the foundational environment in which AI models, agents, and applications are developed, deployed, and executed. Enterprises continue to rely heavily on cloud platforms, data centers, and high-performance computing environments to run agentic AI systems at scale. As a result, securing this layer becomes a priority, since any vulnerability at the infrastructure level can impact the entire AI stack. Organizations are investing in securing compute resources, containerized environments, and cloud-native architectures to ensure safe deployment of AI workloads. Additionally, the growing adoption of hybrid and multi-cloud environments further increases the need for consistent infrastructure-level security controls. This includes runtime protection, workload isolation, and continuous monitoring of infrastructure behavior. Since all higher layers, including models and agents, depend on this foundation, spending at the infrastructure level remains significant, making it the largest segment in the market.

By region, the Asia Pacific is expected to register the highest CAGR during the forecast period.

Asia Pacific is emerging as a high-growth region in the agentic AI security market, driven by the rapid adoption of AI technologies and increasing exposure to AI-enabled cyber threats. According to IBM, Asia Pacific recorded the highest average cost of data breaches in several countries, reflecting growing security challenges in digital environments. AI-driven attacks are also rising across the region, particularly in sectors such as BFSI, telecom, and manufacturing, where automation and AI adoption are accelerating. According to Check Point Software Technologies, organizations in Asia experience a high volume of weekly cyberattacks, many of which are increasingly leveraging AI-based techniques.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=97017233

Unique Features in the Agentic AI Security Market

The Agentic AI Security Market is distinguished by its ability to secure autonomous AI systems that can independently make decisions, execute tasks, and interact across digital environments without constant human supervision. Unlike traditional cybersecurity solutions, agentic AI security platforms are specifically designed to monitor AI agents in real time, detect abnormal behavior patterns, and prevent unauthorized autonomous actions. This capability is becoming increasingly important as enterprises deploy AI copilots, autonomous workflows, and multi-agent systems across business operations.

One of the most unique features of the Agentic AI Security Market is the integration of behavioral intelligence and adaptive threat detection. These platforms continuously learn from AI agent activities, enabling them to identify suspicious actions, prompt manipulation attempts, privilege escalation, and model misuse. By leveraging machine learning and contextual analysis, agentic AI security tools can dynamically respond to evolving threats, making them more effective than static rule-based cybersecurity frameworks.

Another defining characteristic is the focus on securing Large Language Models (LLMs), autonomous agents, and AI orchestration frameworks. The market includes solutions that provide prompt injection protection, AI model governance, API security, data leakage prevention, and identity verification for AI-driven systems. This specialized protection layer ensures that AI agents operate within approved boundaries while maintaining compliance with enterprise security policies and regulatory standards.

The market also stands out for its zero-trust architecture tailored for AI ecosystems. Security providers are developing advanced authentication, access management, and continuous verification mechanisms specifically for AI agents and machine identities. These capabilities help organizations maintain strict control over AI interactions, third-party integrations, and automated decision-making environments, reducing the risk of unauthorized access and cyberattacks.

Major Highlights of the Agentic AI Security Market

The Agentic AI Security Market is witnessing rapid growth due to the increasing adoption of autonomous AI agents across enterprises, government organizations, and digital platforms. As businesses integrate AI-driven automation into customer service, cybersecurity operations, software development, and workflow management, the demand for specialized security solutions that can protect autonomous systems from cyber threats is rising significantly. This growing reliance on AI agents is becoming one of the primary factors accelerating market expansion globally.

A major highlight of the market is the rising focus on securing Large Language Models (LLMs), generative AI platforms, and multi-agent ecosystems. Organizations are increasingly concerned about prompt injection attacks, unauthorized data access, hallucination risks, and AI model manipulation. As a result, security vendors are introducing advanced monitoring, governance, and runtime protection solutions specifically designed for autonomous AI systems, creating a new category within the broader cybersecurity landscape.

Another important highlight is the strong integration of zero-trust security frameworks into agentic AI environments. Enterprises are implementing identity verification, role-based access controls, AI behavior monitoring, and continuous authentication mechanisms to ensure that autonomous agents operate securely within approved boundaries. This shift toward AI-specific zero-trust architectures is helping organizations reduce operational risks while maintaining compliance and control over AI-driven workflows.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=97017233

Top Companies in the Agentic AI Security Market

The agentic AI security market is led by some of the globally established players, such as Microsoft (US), Palo Alto Networks (US), CrowdStrike (US), Straiker (US), SentinelOne (US), Okta (US), Cloudflare (US), Cato Networks (Israel), Check Point Software Technologies (Israel), Securiti (US), HiddenLayer (US), Noma Security (Israel), Obsidian Security (US), Mindgard (UK), DeepKeep (Israel), Enkrypt AI (US), Pillar Security (US), Astrix Security (Israel), Natoma (US), Trufoundry (US), Descope (US), Zenity (Israel), Fiddler AI (US), Openlayer (US), Aembit (US), Lasso Security (Israel), Akto (US), Credo AI (US), Promptfoo (US), Strata Identity (US), Holistic AI (UK), Geordie AI (UK), NeuralTrust (Spain), Usercentrics (Germany). These market players have adopted various strategies, including product launches, partnerships, contracts, expansions, and acquisitions, to strengthen their positions in the agentic AI security market. Organic and inorganic strategies have enabled market players to expand globally by providing emotion detection and response solutions.

Palo Alto Networks (US) is a global security company with strong capabilities in network, cloud, and AI-driven security. In the agentic AI security market, Palo Alto Networks delivers AI-powered security solutions through platforms focused on securing AI models, applications, and autonomous workflows. Its offerings leverage advanced threat intelligence, real-time analytics, and automation to detect anomalous AI behavior, protect data pipelines, and secure agent-driven environments. The company’s capabilities support enterprises in managing AI risks, enforcing policy controls, and ensuring secure deployment of agentic AI systems across complex digital infrastructures.

Microsoft (US) is a global technology company with extensive capabilities in cloud computing, artificial intelligence, and enterprise security. In the agentic AI security market, Microsoft offers AI-driven security solutions through its cloud and security ecosystem, with a focus on protecting AI workloads, data environments, and autonomous systems. Its platforms enable threat detection, AI governance, and continuous monitoring of agent behavior using large-scale telemetry and integrated intelligence. Microsoft supports organizations in securing AI pipelines, maintaining compliance, and managing risks associated with autonomous decision-making systems, ensuring reliable and secure deployment of agentic AI across enterprise environments.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/agentic-ai-security-market-97017233.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Agentic AI Security Market Growth Accelerates with AI Governance and Autonomous Threat Detection Demand Forecast To 2032

Mobile Forensics Market Analysis 2031 Reveals Strong Opportunities in Law Enforcement and Indicates Robust CAGR Supported by Growing Cybersecurity Concerns

“MSAB (Sweden), Oxygen Forensics (US), Magnet Forensics (Canada), Grayshift (US), ElcomSoft (Russia), OpenText (Canada), Exterro (US), Nuix (Australia), SalvationData (China).”
Mobile Forensics Market by Hardware (Forensic Workstations, Extraction & Acquisition, Storage and Evidence Management), Software (Forensic Decryption, Data Extraction, Data Analysis), OS Type, Services (Professional, Managed) – Global Forecast to 2031.

The Mobile Forensics Market is expected to expand at a Compound Annual Growth Rate (CAGR) of 11.8% from USD 5.72 billion in 2026 to USD 9.99 billion by 2031. The use of cutting-edge mobile forensics solutions is being propelled by the increasing demand for quick evidence turnaround and real-time investigative capabilities. In order to support time-sensitive operations and decision-making, investigation teams are increasingly expected to collect and evaluate mobile data in shorter amounts of time. Because of this, there is a need for automated analysis, high-speed extraction, and efficient processes that shorten inquiry times. Because of this, businesses are spending money on solutions that facilitate quicker data processing, better case prioritizing, and effective management of massive amounts of digital evidence.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=29093950

Based on services, the professional services segment is expected to register the highest CAGR during the forecast period.

The professional services segment is gaining significant traction in the mobile forensics market as organizations increasingly depend on specialized expertise to manage complex investigative requirements. Enterprises and law enforcement agencies are engaging service providers for consulting, forensic analysis, training, and incident support to address challenges associated with diverse device ecosystems and evolving data structures. The need for accurate evidence handling, compliance with legal standards, and efficient case management is driving demand for professional services. Additionally, organizations are leveraging these services to enhance internal capabilities, optimize forensic workflows, and ensure effective utilization of advanced forensic tools, further strengthening the dominance of this segment.

By vertical, the BFSI segment is expected to register the highest CAGR during the forecast period.

The BFSI segment is emerging as a high-growth vertical in the mobile forensics market due to the increasing use of mobile devices in financial transactions, digital banking, and customer interactions. Financial institutions are adopting mobile forensic solutions to investigate fraud, detect unauthorized activities, and analyze transaction-related data across mobile platforms. The growing sophistication of financial fraud and the need for rapid incident response are driving demand for advanced forensic tools that enable detailed analysis of mobile-based financial activities. Additionally, regulatory requirements and the need to maintain data integrity and audit trails are encouraging BFSI organizations to invest in scalable and efficient forensic solutions.

By region, Asia Pacific is expected to register the highest CAGR during the forecast period.

Asia Pacific is expected to witness the fastest growth in the mobile forensics market, driven by rapid digital transformation, increasing smartphone penetration, and expanding adoption of mobile-based services across emerging economies. Countries in the region are experiencing a surge in digital transactions, mobile applications, and connected ecosystems, leading to a higher volume of mobile data requiring forensic analysis. Governments and enterprises are investing in digital investigation capabilities to address evolving security challenges and strengthen cyber resilience. Additionally, the growing awareness of digital evidence in legal and investigative processes, along with increasing investments in cybersecurity infrastructure, is contributing to the strong growth of the mobile forensics market in the Asia Pacific.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=29093950

Unique Features in the Mobile Forensics Market

The Mobile Forensics Market is distinguished by its ability to extract, preserve, analyze, and present digital evidence from smartphones, tablets, and wearable devices in a legally admissible manner. One of the most unique features of this market is advanced data recovery technology, which enables investigators to retrieve deleted messages, multimedia files, call logs, application data, and encrypted content from damaged or locked devices. These capabilities are increasingly essential for law enforcement agencies, cybersecurity teams, and enterprises dealing with cybercrime and data breaches.

Another key feature is support for multi-platform and cross-device investigations. Modern mobile forensics solutions are designed to work across diverse operating systems such as Android, iOS, and emerging IoT-connected mobile ecosystems. This interoperability allows investigators to perform unified forensic analysis across multiple devices and cloud-connected environments, improving efficiency and reducing investigation complexity in enterprise and criminal cases.

Cloud and app-based forensic analysis is also a defining feature of the Mobile Forensics Market. With the rapid growth of social media platforms, messaging apps, and cloud backups, forensic tools now specialize in extracting evidence from applications such as WhatsApp, Telegram, Signal, Facebook, and cloud storage services. This capability helps investigators uncover hidden communication patterns, digital footprints, and user behavior data that are critical in modern investigations.

Major Highlights of the Mobile Forensics Market

The Mobile Forensics Market is experiencing strong global growth due to the rapid increase in smartphone usage, mobile-based cybercrimes, and digital investigations across industries. Law enforcement agencies, government organizations, and enterprises are increasingly adopting mobile forensic solutions to investigate cyberattacks, fraud, insider threats, and criminal activities. The growing dependence on mobile devices for communication, banking, and business operations continues to expand the demand for advanced forensic technologies.

One of the major highlights of the market is the rising adoption of cloud-enabled and AI-powered forensic platforms. Modern forensic tools now integrate artificial intelligence, machine learning, and automation to accelerate evidence collection, improve data analysis accuracy, and reduce investigation time. These advanced capabilities help investigators process large volumes of mobile data efficiently while identifying hidden patterns, suspicious behavior, and digital evidence more effectively.

The market is also witnessing significant demand from law enforcement and defense sectors. Governments worldwide are strengthening cybersecurity frameworks and digital investigation capabilities to combat organized crime, terrorism, financial fraud, and cyber espionage. Mobile forensics solutions play a critical role in extracting evidence from encrypted smartphones, messaging applications, and cloud-connected devices, making them essential tools for national security and criminal investigations.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=29093950

Top Companies in the Mobile Forensics Market

The mobile forensics market is led by some of the globally established players, such as Cellebrite (Israel), MSAB (Sweden), Oxygen Forensics (US), Magnet Forensics (Canada), Grayshift (US), ElcomSoft (Russia), OpenText (Canada), Exterro (US), Nuix (Australia), and SalvationData (China). These market players have adopted various strategies, such as product launches, partnerships, contracts, expansions, and acquisitions, to strengthen their position in the mobile forensics market. Organic and inorganic strategies have enabled market players to expand globally by providing advanced mobile forensics solutions.

MSAB is a digital forensics company that provides mobile forensic solutions designed for law enforcement agencies, government organizations, and enterprise investigators. The company’s flagship platform, XRY, enables secure extraction, decoding, and analysis of data from a wide range of mobile devices, including smartphones, tablets, and IoT endpoints. MSAB’s solutions support both logical and physical data acquisition, enabling investigators to recover deleted data, application artifacts, communication records, and location intelligence. The platform integrates advanced analytics, reporting, and visualization capabilities, allowing users to correlate data across multiple sources and accelerate investigative workflows. MSAB emphasizes forensic integrity, ensuring that all extracted data is handled in a legally admissible manner through standardized processes and audit trails. The company continuously enhances device and OS compatibility, supporting evolving mobile ecosystems and encrypted environments. Through its focus on automation, scalability, and interoperability with digital forensic labs, MSAB enables faster case resolution, improved evidence management, and efficient handling of large volumes of mobile data across complex investigative environments.

Grayshift is a mobile digital forensics company specializing in advanced solutions for accessing and analyzing encrypted mobile devices. The company’s flagship product, GrayKey, is widely used by law enforcement and government agencies to unlock and extract data from smartphones, including devices with strong encryption and security controls. Grayshift’s platform supports comprehensive data acquisition, including messages, application data, system files, and deleted artifacts, enabling investigators to gain deep visibility into mobile device activity. The company focuses on overcoming encryption challenges through continuous innovation in device unlocking techniques and secure access methodologies. Grayshift integrates its solutions with broader forensic workflows, allowing seamless data transfer, analysis, and reporting across investigative platforms. Its tools are designed for scalability and operational efficiency, supporting both field and lab-based investigations. By combining secure access capabilities with advanced data parsing and analytics, Grayshift enables agencies to accelerate evidence collection, reduce investigation timelines, and enhance decision-making in high-priority cases involving digital evidence from mobile devices.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/mobile-forensics-market-29093950.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Mobile Forensics Market Analysis 2031 Reveals Strong Opportunities in Law Enforcement and Indicates Robust CAGR Supported by Growing Cybersecurity Concerns

Seed Treatment Market Repot 2025-2030: Future Business Growth, Revenue, Regional Analysis, and Top Companies

“MarketsandMarkets™”
Seed Treatment Market by Type, Application Technique (Coating, Dressing, Pelleting), Function (Seed Protection and Seed Enhancement), Formulation, Crop Type (Cereals & Grains, Oilseeds, Fruits & Vegetables), and Region – Global Forecast to 2030

According to a research report published by MarketsandMarkets™, the global seed treatment market is projected to grow from USD 7.84 billion in 2025 to USD 11.39 billion by 2030, registering a CAGR of 7.7% during the forecast period. The market growth is primarily driven by the increasing adoption of high-value hybrid and genetically modified seeds, which require enhanced early-stage crop protection. In addition, regulatory restrictions on foliar pesticide applications and the growing global emphasis on sustainable agriculture are accelerating the adoption of seed-applied treatment solutions.

Seed Treatment Market

Technological advancements in seed treatment formulations and increasing integration with precision farming systems are further improving treatment efficiency and application accuracy. Growing awareness among farmers regarding crop productivity and supportive government initiatives, particularly across emerging economies, are also contributing to the expansion of the seed treatment industry.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=503

Seed Pelleting Segment Holds Significant Market Share

Based on application technique, the seed pelleting segment accounts for a significant share of the global seed treatment market. Seed pelleting enhances seed size, shape, and uniformity, improving planting efficiency and crop stand establishment.

The technique is particularly advantageous for small and irregularly shaped seeds such as vegetables, herbs, and flowers, enabling precision planting and improved singulation in mechanical seeders. Seed pelleting also facilitates the incorporation of plant protection products, micronutrients, and growth stimulants within the pellet matrix, ensuring targeted delivery during germination.

Growing demand for high-performance seeds in horticulture and precision farming, along with advancements in pelleting materials and equipment, continues to support the adoption of seed pelleting technologies worldwide.

Oilseeds Segment Accounts for Major Share by Crop Type

By crop type, the oilseeds segment holds a substantial share in the seed treatment market owing to the high economic value of crops such as soybean, canola, and sunflower.

These crops are highly susceptible to early-stage pest infestations and soil-borne diseases, increasing the need for effective seed treatment solutions to protect yield potential. Rising adoption of hybrid and genetically modified oilseed varieties has further strengthened the demand for advanced seed treatment products.

Additionally, ongoing advancements in treatment technologies and the growing focus on sustainable agricultural practices are encouraging the use of both chemical and biological seed treatments across oilseed cultivation.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=503

North America Leads the Global Seed Treatment Market

North America dominates the global seed treatment market, supported by the widespread adoption of genetically modified and premium hybrid seeds, particularly for crops such as corn, soybean, and canola.

Farmers across the region are increasingly prioritizing protection of high-value seed investments through early-stage defense against pests and diseases, making seed treatments an essential component of modern crop production systems.

The region benefits from advanced agricultural infrastructure and high awareness regarding modern crop protection practices. Regulatory restrictions on foliar pesticide use in the US and Canada have also accelerated the transition toward more targeted and environmentally sustainable solutions such as seed treatments.

Furthermore, increasing demand for sustainable agricultural practices has boosted the adoption of biological seed treatments in response to growing concerns related to soil health and consumer preference for residue-free crops.

Continuous investments by research institutions and industry participants in next-generation seed-applied technologies, along with the integration of seed treatments into precision farming systems and conservation tillage practices, continue to strengthen North America’s leadership position in the market.

Regional Report:

 

Leading Seed Treatment Companies:

The report profiles key players such as BASF SE (Germany), Bayer AG (Germany), UPL (India), Corteva (US), Croda (UK), FMC (US), Nufarm (Australia), Syngenta (US), Germains Seed (UK), Sumitomo Chemicals (Japan), Covestro AG (Germany), Koppert (Netherlands), Novonesis Group (Denmark), Syensqo (Belgium), and Centor Group (Netherlands).

SYNGENTA (Switzerland)

Syngenta is a global leader in the seed treatment market, known for its innovative Seedcare portfolio that includes flagship products like Cruiser 350S, Apron XL. The company operates across key segments: Crop Protection, which houses its seed treatment solutions; Seeds, offering high-performance crop varieties; Biologicals, focusing on sustainable microbial treatments; and Digital Agriculture, enhancing precision in seed applications. Syngenta’s integrated approach, combining chemical, biological, and digital innovations, positions it at the forefront of sustainable and high-performance seed protection solutions.

In July 2024, Syngenta Crop Protection entered a strategic collaboration with Ginkgo Bioworks, leveraging their Ag Biologicals platform. The partnership focuses on engineering and optimizing a microbial strain to enable cost-effective, large-scale production of a key secondary metabolite from Syngenta’s biologicals pipeline. By combining Ginkgo’s strain-engineering and machine-learning expertise with Syngenta’s biotech ambitions, the deal aims to significantly accelerate the time-to-market for an innovative biological seed solution.

BASF SE (Germany)

BASF SE is a leading player in the seed treatment market, offering a robust portfolio that includes products like Poncho, Stamina, and Vercoras, designed for broad-spectrum protection and enhanced early plant development. Operating through its Agricultural Solutions segment, BASF integrates chemical and biological innovations to meet global farming needs. Its Seeds & Traits and Biologicals divisions focus on developing resilient seeds and sustainable microbial treatments, while its Digital Farming (xarvio) platform supports precision application. With a strong focus on innovation and sustainability, BASF delivers integrated seed treatment solutions to boost crop performance and resilience.

BASF SE’s strengths lie in its robust R&D capabilities, advanced formulation expertise, and a diverse, integrated portfolio spanning chemical, biological, and digital seed treatment solutions. With a global presence in over 90 countries, the company ensures wide market reach and tailored offerings. Its strong commitment to sustainability is reflected in eco-efficient innovations and the xarvio digital farming platform. Strategic collaborations and a legacy of scientific excellence further reinforce BASF’s position as a trusted, forward-looking leader in the seed treatment and agricultural solutions market. In October 2023, BASF launched Poncho VOTiVO Precise, a next-generation seed treatment that combines insecticidal and nematocidal protection in a single solution. It pairs the insecticide clothianidin with the biological agent Bacillus firmus I-1582, forming a living biological barrier around the developing plant roots. This dual-action formulation delivers early-season insect control and long-lasting nematode suppression, supporting healthier root systems and stronger crop establishment.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=503

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/seed-treatment-market-503.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Seed Treatment Market Repot 2025-2030: Future Business Growth, Revenue, Regional Analysis, and Top Companies